The EMCDDA’s European Drug Report 2021 highlights a significant increase in THC content of cannabis in Europe, as well as prevalent cannabis use amongst Europeans and an increase in home cultivation during the COVID-19 pandemic.
Cannabis resin sold in Europe is more potent than ever before, EU officials have warned.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) says the THC content of cannabis resin is now on average between 20% and 28% – almost twice that of cannabis flower. THC content of cannabis flower is still as high as it has ever been, however.
Cannabis products available in Europe now include high-THC content commodities as well as new forms adulterated with synthetic cannabinoids sold on the illicit market. These exist alongside a range of goods containing cannabis extracts – but low levels of TCH – sold commercially.
The data is contained in the EMCDDA’s European Drug Report 2021, which raises concerns about…